Arteris Closes Acquisition of Cycuity
Arteris (Nasdaq: AIP) announced it has closed its acquisition of Cycuity, a semiconductor cybersecurity assurance technology provider, on Jan. 14, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Arteris (Nasdaq: AIP) announced it has closed its acquisition of Cycuity, a semiconductor cybersecurity assurance technology provider, on Jan. 14, 2026. The deal combines Arteris system IP with Cycuity's hardware security assurance capabilities to address rising hardware threats and secure on-chip data movement from AI data centers to edge devices. The release cites a >15x increase in reported hardware CVEs over five years per NIST, underscoring demand for solutions that protect SoC functionality, performance, and schedules. The acquisition expands Arteris's product portfolio and positions the company to offer integrated security-focused IP and tools for semiconductor customers.
Positive
- Acquisition closed on Jan. 14, 2026
- Combines Arteris system IP with Cycuity hardware security assurance technology
- Expands product portfolio to secure on-chip data movement from AI data centers to edge devices
Negative
- Reported hardware CVEs rose by over 15x in five years, indicating increased security risk
- Threat landscape expansion could require additional R&D to maintain secure SoC performance
Details
News Market Reaction – AIP
On Jan 15, the first trading day after this news, AIP closed 1.58% above the previous close.
Data tracked by StockTitan Argus for the Jan 15 session.
Key Figures
- Q3 2025 revenue
- $17.4M
- Q3 2025, up from $14.7M a year ago
- ACV plus royalties
- $74.9M
- Q3 2025, +24% year-over-year
- Remaining performance obligations
- $104.7M
- Q3 2025, +34% year-over-year
- GAAP net loss
- $9.0M
- Q3 2025 net loss, or $0.21 per share
- Shelf registration capacity
- $200,000,000
- Total potential offerings under S-3 shelf filed Dec 11, 2025
- ATM program size
- $75,000,000
- Common stock that may be sold via Jefferies ATM
- Insider sale
- 40,000 shares at $16.4618
- Bayview Legacy, LLC sale on Dec 4, 2025 under Rule 10b5-1 plan
- Short interest
- 3.76%
- Short interest as a percent of float; days to cover 3.35
Historical Context
-
Announced definitive agreement to acquire Cycuity to add cybersecurity IP.
-
Black Sesame licensed Ncore 3 and FlexNoC 5 for intelligent driving SoCs.
-
Blaize adopted FlexNoC 5 to enhance scalable, efficient edge AI solutions.
-
Q3 2025 revenue growth with higher losses and updated FY25 guidance.
-
Altera licensed Arteris IP and tools for next-gen FPGA and SoC FPGA designs.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
semiconductor cybersecurity assurance technical
common vulnerabilities and exposures (cves) technical
national institute of standards and technology (nist) technical
system-on-chip technical
soc technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Arteris adds to product portfolio to address secure data movement from AI data centers to edge devices with leading semiconductor cybersecurity assurance technology.
CAMPBELL, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced it has closed its previously announced acquisition of Cycuity, Inc., a leading provider and domain expert of semiconductor cybersecurity assurance technology.
Semiconductor cybersecurity assurance is becoming critical to all types of chip designs, as the threat landscape has expanded to the hardware layer. Silicon vulnerabilities can result in compromised systems exposing unprotected information, a trend accelerated by the proliferation of AI and chiplets. Reported new Common Vulnerabilities and Exposures (CVEs) in hardware grew by over 15 times in the last five years, according to the US Department of Commerce’s National Institute of Standards and Technology (NIST). As such, there is a growing need for technology solutions that help to increase semiconductor security without risking SoC functionality, performance, and schedules.
By combining innovative system IP from Arteris with leading silicon hardware security assurance technology from Cycuity, the acquisition positions Arteris to address the growing concern around hardware security. The volume of sophisticated cyberattacks is increasing, targeting the vast amounts of unsecured data moving through semiconductors, from AI data centers to a wide range of edge devices. With this acquisition, Arteris broadens its commitment to deliver comprehensive products and solutions which help customers achieve secure on-chip data movement.
About Arteris
Arteris is a leading provider of semiconductor technology that accelerates the creation of high-performance, power-efficient silicon with built-in safety, reliability, and security. Innovative Arteris products are designed to optimize data movement and help ease complexity in the modern AI era with network-on-chip (NoC) interconnect intellectual property (IP), system-on-chip (SoC) software for integration automation and hardware security assurance. All are used by the world's top technology companies to improve overall performance and engineering productivity, reduce risk, lower costs, and bring cutting-edge designs to market faster. Learn more at arteris.com.
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including but not limited to statements regarding the acquisition positioning Arteris to address growing concerns around hardware security. Words such as "may," "will," "could," "expect," "approximately," "believe," "estimate," "future," "guidance," "outlook," and similar words or expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements allow potential investors an opportunity to understand Company management’s beliefs and opinions regarding potential future outcomes, which may be used as a factor by potential investors in evaluating an investment. Although forward-looking statements are based upon what Company management believes may be reasonable future outcomes, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in a forward-looking statement. Therefore, such statements are not guarantees. Arteris assumes no obligation to update any forward-looking statement in this release, except as required by law. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from the Company’s current expectations. Important factors that could cause actual results to differ materially from those anticipated in the Company’s forward-looking statements include, but are not limited to, the factors described under the heading “Risk Factors” in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 filed with the Securities and Exchange Commission on November 4, 2025.
© 2004-2026 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at https://www.arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners.
Investor Contacts:
Arteris Inc.
Nick Hawkins
IR@arteris.com
Sapphire Investor Relations, LLC
Erica Mannion and Michael Funari
+1 617 542 6180
IR@arteris.com
Media Contact:
Arteris Inc.
Gina Jacobs
+1 408 560 3044
newsroom@arteris.com
This press release was published by a CLEAR® Verified individual.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.